Our facilities support the delivery of pioneering translational research which is designed to improve healthcare for all.
We continually invest in the very latest technologies to accelerate the development of new diagnostic procedures and medical treatments for a wide range of conditions.
Our core facilities provide the cutting edge equipment and optimum environment needed for high quality translational research projects.
Immune Monitoring Facility: A state-of-the-art laboratory allowing researchers to carry out immune monitoring on samples taken from volunteers and patients. It provides investigators with equipment and support for cell sorting, acquisition and analysis of flow cytometric data. It is located at Guy’s Hospital.
Clinical Research Facilities: Ideal for clinicians, researchers and allied health professionals looking to conduct patient and volunteer studies. We have a diverse mix of facilities at both Guy’s and St Thomas’ hospitals and Evelina London Children’s Hospital.
Genomics Facility: Supports the discovery of novel approaches to the prevention, diagnosis and therapy of major diseases. A range of services is offered to clinical and academic investigators working with the ultimate aim of improving patient outcomes. The facility is on the 7th floor of Guy’s Tower Wing in the Department of Medical and Molecular Genetics at Guy’s Hospital.
Advanced Therapy Manufacturing Facility: The GMP (Good Manufacturing Practice) Unit provides a flexible space for the production of cell and gene therapies for clinical trials. The unit enables the use in studies of Advanced Therapy Medicinal Products (ATMPs), which have heralded a new era in patient care and treatment. The GMP Unit is located within Guy’s Hospital.
BioResource Facility: The BioResource has established groups of healthy volunteers and patients who have provided samples (of blood or saliva) and agreed to be recalled by genotype and phenotype to participate in medical research and trials and also includes Twins volunteers belonging to the TwinsUK registry, which is one of the most well-characterised cohorts in the world. Working closely within the NHS infrastructure, the BioResource plans to raise the profile of clinical research and the importance of NIHR BioResource participants in facilitating research studies.
Translational Bioinformatics Core: Focuses on translational projects designed to identify novel therapeutic targets and disease biomarkers. Also enables the dissection of molecular mechanisms underpinning diseases and aims to support the application of advanced bioinformatics analyses in scientific projects.